Loratadine
NDC 70010-162, Loratadine, tablet, from Granules Pharmaceuticals Inc..
- Product NDC
- 70010-162
- Status
- Listed
- Labeler
- Granules Pharmaceuticals Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA210722
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70010-162 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LORATADINE10 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70010-162-01 | 70010016201 | 100 TABLET in 1 BOTTLE (70010-162-01) |
| 70010-162-03 | 70010016203 | 30 TABLET in 1 BOTTLE (70010-162-03) |
| 70010-162-34 | 70010016234 | 300 TABLET in 1 BOTTLE (70010-162-34) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
NADAC price for package 70010016201
GET /v1/drugs/nadac/70010016201NADAC price for package 70010016234
GET /v1/drugs/nadac/70010016234
Use it
Look up 70010-162 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70010-162 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70010-162. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.